BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 17996827)

  • 1. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure.
    Ghali JK; Boehmer J; Feldman AM; Saxon LA; Demarco T; Carson P; Yong P; Galle EG; Leigh J; Ecklund FL; Bristow MR
    J Card Fail; 2007 Nov; 13(9):769-73. PubMed ID: 17996827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac resynchronization therapy: device-based medicine for heart failure.
    Philippon F
    J Card Surg; 2004; 19(3):270-4. PubMed ID: 15151661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.
    Bristow MR; Saxon LA; Boehmer J; Krueger S; Kass DA; De Marco T; Carson P; DiCarlo L; DeMets D; White BG; DeVries DW; Feldman AM;
    N Engl J Med; 2004 May; 350(21):2140-50. PubMed ID: 15152059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRT plus ICD in congestive heart failure. Use of cardiac resynchronization therapy and an implantable cardioverter-defibrillator in heart failure patients with abnormal left ventricular dysfunction.
    Aronow WS
    Geriatrics; 2005 Feb; 60(2):24, 26-8. PubMed ID: 15742919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.
    Abraham WT; Young JB; León AR; Adler S; Bank AJ; Hall SA; Lieberman R; Liem LB; O'Connell JB; Schroeder JS; Wheelan KR;
    Circulation; 2004 Nov; 110(18):2864-8. PubMed ID: 15505095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term retention of cardiac resynchronization therapy.
    Knight BP; Desai A; Coman J; Faddis M; Yong P
    J Am Coll Cardiol; 2004 Jul; 44(1):72-7. PubMed ID: 15234410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac resynchronization therapy improves central sleep apnea and Cheyne-Stokes respiration in patients with chronic heart failure.
    Sinha AM; Skobel EC; Breithardt OA; Norra C; Markus KU; Breuer C; Hanrath P; Stellbrink C
    J Am Coll Cardiol; 2004 Jul; 44(1):68-71. PubMed ID: 15234409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ongoing trials of cardiac resynchronisation.
    Cleland JG; Ghosh J; Khan N; Hurren S; Kaye G
    Minerva Cardioangiol; 2003 Apr; 51(2):197-207. PubMed ID: 12783075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.
    Young JB; Abraham WT; Smith AL; Leon AR; Lieberman R; Wilkoff B; Canby RC; Schroeder JS; Liem LB; Hall S; Wheelan K;
    JAMA; 2003 May; 289(20):2685-94. PubMed ID: 12771115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of benefit and early hazard of bucindolol for Class IV heart failure.
    Anderson JL; Krause-Steinrauf H; Goldman S; Clemson BS; Domanski MJ; Hager WD; Murray DR; Mann DL; Massie BM; McNamara DM; Oren R; Rogers WJ;
    J Card Fail; 2003 Aug; 9(4):266-77. PubMed ID: 13680547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac resynchronization in chronic heart failure.
    Abraham WT; Fisher WG; Smith AL; Delurgio DB; Leon AR; Loh E; Kocovic DZ; Packer M; Clavell AL; Hayes DL; Ellestad M; Trupp RJ; Underwood J; Pickering F; Truex C; McAtee P; Messenger J;
    N Engl J Med; 2002 Jun; 346(24):1845-53. PubMed ID: 12063368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF.
    Deedwania PC; Giles TD; Klibaner M; Ghali JK; Herlitz J; Hildebrandt P; Kjekshus J; Spinar J; Vitovec J; Stanbrook H; Wikstrand J;
    Am Heart J; 2005 Jan; 149(1):159-67. PubMed ID: 15660048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias.
    Higgins SL; Hummel JD; Niazi IK; Giudici MC; Worley SJ; Saxon LA; Boehmer JP; Higginbotham MB; De Marco T; Foster E; Yong PG
    J Am Coll Cardiol; 2003 Oct; 42(8):1454-9. PubMed ID: 14563591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiac resynchronization therapy-current status and future perspectives].
    Stellbrink C; Breithardt OA
    Herz; 2003 Nov; 28(7):607-14. PubMed ID: 14689121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of changing oedematous states on the QRS duration: implications for cardiac resynchronization therapy and implantable cardioverter/defibrillator implantation.
    Madias JE
    Europace; 2005 Mar; 7(2):158-64. PubMed ID: 15763531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure.
    Smooke S; Horwich TB; Fonarow GC
    Am Heart J; 2005 Jan; 149(1):168-74. PubMed ID: 15660049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis.
    Hudson MP; O'Connor CM; Gattis WA; Tasissa G; Hasselblad V; Holleman CM; Gaulden LH; Sedor F; Ohman EM
    Am Heart J; 2004 Mar; 147(3):546-52. PubMed ID: 14999208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure.
    Cleland JG; Abraham WT; Linde C; Gold MR; Young JB; Claude Daubert J; Sherfesee L; Wells GA; Tang AS
    Eur Heart J; 2013 Dec; 34(46):3547-56. PubMed ID: 23900696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Does cardiac resynchronization therapy improve nitric oxide concentration in exhaled gas?].
    Hiratsuji T; Adachi H; Isobe N; Tada H; Toyama T; Naito S; Hoshizaki H; Oshima S; Taniguchi K
    J Cardiol; 2004 Jan; 43(1):11-5. PubMed ID: 14750409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure.
    Gustafsson I; Brendorp B; Seibaek M; Burchardt H; Hildebrandt P; Køber L; Torp-Pedersen C;
    J Am Coll Cardiol; 2004 Mar; 43(5):771-7. PubMed ID: 14998615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.